Clinical Trial Update: Thiazolidinediones Or Sulphonylureas and Cardiovascular Accidents.Intervention Trial [Phase 4]

View source ↗

Summary

Phase 4 trial update examining cardiovascular safety of thiazolidinediones versus sulphonylureas in patients with type 2 diabetes and cardiovascular disease; ou…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Italian Society of Diabetology | Conditions: Type 2 Diabetes Mellitus, Cardiovascular Disease | Phase 4 | Status: UNKNOWN